Sibel Guerler
About Sibel Guerler
Sibel Guerler is the Head of Innovation, Partnerships & Process Optimization at Bristol Myers Squibb, with extensive experience in pharmacovigilance and digital insights.
Current Role at Bristol Myers Squibb
Sibel Guerler currently holds the position of Head, Innovation, Partnerships & Process Optimization, World Wide Patient Safety at Bristol Myers Squibb. In this role, she is responsible for driving innovation, forming strategic partnerships, and optimizing processes to enhance patient safety on a global scale. Her work involves leveraging her extensive background in digital insights and her experience in safety-focused roles to deliver improvements in patient safety outcomes.
Previous Roles at Bristol Myers Squibb
Before taking on her current role, Sibel Guerler served as the Director of Digital Insights and Innovation for Worldwide Patient Safety at Bristol Myers Squibb from 2020 to 2022. During her tenure, she was based in Boudry, Neuchâtel, Switzerland, and focused on integrating digital tools and insights to support and enhance patient safety initiatives.
Experience at Celgene
From 2018 to 2020, Sibel Guerler worked at Celgene as the Associate Director of Global Case Management in Switzerland. She was responsible for managing case-related processes globally, ensuring safety and compliance in patient case management.
Roles at Johnson & Johnson
Sibel Guerler has a diverse background at Johnson & Johnson, where she held multiple roles. She served as the Cross Sector Country Safety Team Lead for the Alpine Cluster from 2016 to 2018 in Zug, Switzerland, and as a Vendor Relationship Manager from 2014 to 2016 in Berne, Switzerland. Prior to that, she was a Pharmacovigilance Manager at Crucell, a Johnson & Johnson company, from 2012 to 2014 and a Pharmacovigilance Specialist from 2010 to 2011.
Educational Background
Sibel Guerler studied Molecular Biology at Universität Basel, where she achieved a Master of Science (MS) from 2005 to 2010. Her strong educational background in molecular biology has provided her with the scientific foundation necessary to excel in various pharmacovigilance and patient safety roles.